Applied Therapeutics, Inc. - APLT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 04, 2026 | — | D | D | 200,000.0 | — | — | 0.0 | View | |
| Feb 04, 2026 | — | D | D | 16,500.0 | — | — | 0.0 | View | |
| Feb 04, 2026 | — | D | D | 16,500.0 | — | — | 0.0 | View | |
| Feb 04, 2026 | — | D | D | 10,230.0 | — | — | 0.0 | View | |
| Feb 04, 2026 | — | D | D | 20,460.0 | — | — | 0.0 | View | |
| Feb 04, 2026 | — | U | D | 42,500.0 | — | — | 0.0 | View | |
| Feb 04, 2026 | — | D | D | 22,500.0 | — | — | 42,500.0 | View | |
| Feb 03, 2026 | Chief Commercial Officer | U | D | 5,753.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | Chief Commercial Officer | D | D | 862,500.0 | — | — | 5,753.0 | View | |
| Feb 03, 2026 | Chief Commercial Officer | A | A | 312,500.0 | 0.0 | 0.0 | 868,253.0 | View | |
| Feb 03, 2026 | See Remarks | U | D | 57,111.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | See Remarks | D | D | 1,000,000.0 | — | — | 57,111.0 | View | |
| Feb 03, 2026 | See Remarks | A | A | 437,500.0 | 0.0 | 0.0 | 1,057,111.0 | View | |
| Feb 03, 2026 | — | D | D | 200,000.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | D | D | 16,500.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | D | D | 16,500.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | D | D | 10,230.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | D | D | 20,460.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | U | D | 42,500.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | D | D | 22,500.0 | — | — | 42,500.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | D | D | 40,502.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | D | D | 150,000.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | D | D | 16,500.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | D | D | 16,500.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | D | D | 10,230.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | D | D | 20,460.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | U | D | 152,959.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | D | D | 2,375,000.0 | — | — | 152,959.0 | View | |
| Feb 03, 2026 | Chief Financial Officer | A | A | 1,187,500.0 | 0.0 | 0.0 | 2,527,959.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | D | D | 4,883.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | D | D | 19,531.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | U | D | 60,901.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | D | D | 1,235,915.0 | — | — | 60,901.0 | View | |
| Feb 03, 2026 | Chief Medical Officer | A | A | 437,500.0 | 0.0 | 0.0 | 1,296,816.0 | View | |
| Feb 03, 2026 | — | D | D | 23,941.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | D | D | 200,000.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | D | D | 16,500.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | D | D | 16,500.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | D | D | 10,230.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | D | D | 20,460.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | U | D | 82,922.0 | — | — | 0.0 | View | |
| Feb 03, 2026 | — | D | D | 22,500.0 | — | — | 82,922.0 | View | |
| Jan 02, 2026 | Chief Financial Officer | A | A | 150,000.0 | 0.0 | 0.0 | 1,340,459.0 | View | |
| Dec 18, 2025 | — | S | D | 43,000.0 | 0.112 | 4,816.0 | 65,000.0 | View |